欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IS/H/0609/001
药品名称Nintedanib Teva
活性成分
    • nintedanib esilate 100.0 mg
剂型Capsule, soft
上市许可持有人Teva GmbH, Graf-Arco-Str.3, 89079 Ulm, Germany
参考成员国 - 产品名称Iceland (IS)
Nintedanib Teva
互认成员国 - 产品名称
    • Sweden (SE)
    • Germany (DE)
      Nintedanib Adalvo 100 mg Weichkapseln
    • Norway (NO)
    • Denmark (DK)
    • Finland (FI)
    • Belgium (BE)
      Nintedanib Teva 100 mg zachte capsules
    • Poland (PL)
      Nintedanib Adalvo
    • Netherlands (NL)
    • Latvia (LV)
    • Luxembourg (LU)
    • Lithuania (LT)
      Nintedanib Adalvo 100 mg minkštosios kapsulės
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Czechia (CZ)
      Nintedanib Adalvo
    • Spain (ES)
    • Romania (RO)
      Nintedanib Adalvo 100 mg capsule moi
    • Portugal (PT)
    • Slovakia (SK)
    • Italy (IT)
    • Croatia (HR)
    • Greece (GR)
许可日期2023/12/21
最近更新日期2024/04/26
药物ATC编码
    • L01EX09 nintedanib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase